Shanshan S. Su

The Key Laboratory Of Interventional Pulmonology Of Zhejiang Province
Wenzhou, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 18 publications

Corrigendum to "Natsudaidain alleviates acute lung injury through the PI3K/Akt and P53 signaling pathways by inhibiting MLE-12 apoptosis: a network pharmacology study and experimental validation" [Int. Immunopharmacol. 164 (2025) 115396].

Corrigendum to "Natsudaidain alleviates acute lung injury through the PI3K/Akt and P53 signaling pathways by inhibiting MLE-12 apoptosis: a network pharmacology study and experimental validation" [Int. Immunopharmacol. 164 (2025) 115396].

Journal: International immunopharmacology

Published: September 07, 2025

Antibiotic exposure impairs the efficacy of first-line chemoimmunotherapy in non-small cell lung cancer through the regulation of gut microbiome and bile acid metabolism.

Antibiotic exposure impairs the efficacy of first-line chemoimmunotherapy in non-small cell lung cancer through the regulation of gut microbiome and bile acid metabolism.

Journal: Precision clinical medicine

Published: August 19, 2025

Natsudaidain alleviates acute lung injury through the PI3K/Akt and P53 signaling pathways by inhibiting MLE-12 apoptosis: a network pharmacology study and experimental validation.

Natsudaidain alleviates acute lung injury through the PI3K/Akt and P53 signaling pathways by inhibiting MLE-12 apoptosis: a network pharmacology study and experimental validation.

Journal: International immunopharmacology

Published: April 15, 2025

Comparative analysis of six nutritional scores in predicting prognosis of COVID-19 patients.

Comparative analysis of six nutritional scores in predicting prognosis of COVID-19 patients.

Journal: Frontiers in nutrition

Published: September 24, 2024

Lysophosphatidylcholine 14:0 Alleviates Lipopolysaccharide-Induced Acute Lung Injury via Protecting Alveolar Epithelial Barrier by Activation of Nrf2/HO-1 Pathway.

Lysophosphatidylcholine 14:0 Alleviates Lipopolysaccharide-Induced Acute Lung Injury via Protecting Alveolar Epithelial Barrier by Activation of Nrf2/HO-1 Pathway.

Journal: Journal of inflammation research

Published: September 08, 2024

3-methyladenine ameliorates acute lung injury by inhibiting oxidative damage and apoptosis.

3-methyladenine ameliorates acute lung injury by inhibiting oxidative damage and apoptosis.

Journal: Heliyon

Published: January 04, 2024

Association between the modified lung immune predictive index and clinical outcomes of advanced non-small cell lung cancer treated with first-line immune checkpoint inhibitors combined with chemotherapy.

Association between the modified lung immune predictive index and clinical outcomes of advanced non-small cell lung cancer treated with first-line immune checkpoint inhibitors combined with chemotherapy.

Journal: Journal of thoracic disease

Published: September 28, 2023

Diagnostic value of metagenomic next-generation sequencing of bronchoalveolar lavage fluid for the diagnosis of suspected pneumonia in immunocompromised patients.

Diagnostic value of metagenomic next-generation sequencing of bronchoalveolar lavage fluid for the diagnosis of suspected pneumonia in immunocompromised patients.

Journal: BMC infectious diseases

Published: December 24, 2021

Inhibition of protein kinase C alpha attenuates lipopolysaccharide-triggered acute lung injury by alleviating the hyperinflammatory response and oxidative stress.

Inhibition of protein kinase C alpha attenuates lipopolysaccharide-triggered acute lung injury by alleviating the hyperinflammatory response and oxidative stress.

Journal: Annals of translational medicine

Published: November 05, 2021

Severe Chlamydia psittaci pneumonia: clinical characteristics and risk factors.

Severe Chlamydia psittaci pneumonia: clinical characteristics and risk factors.

Journal: Annals of palliative medicine

Published: May 21, 2021

The diagnostic performance of galactomannan detection in invasive pulmonary aspergillosis with severe and critically ill influenza

The diagnostic performance of galactomannan detection in invasive pulmonary aspergillosis with severe and critically ill influenza

Journal: Zhonghua yi xue za zhi

Published: April 20, 2021

Performance of different methods for detecting T790M mutation in the plasma of patients with advanced NSCLC after developing resistance to first-generation EGFR-TKIs in a real-world clinical setting.

Performance of different methods for detecting T790M mutation in the plasma of patients with advanced NSCLC after developing resistance to first-generation EGFR-TKIs in a real-world clinical setting.

Journal: Molecular and clinical oncology

Published: May 22, 2020

Showing 1-12 of 18

Last Updated: 09/26/2026